Article Information
History
- October 6, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Cécile Kremer, MSc1,*,†,
- Lander Willem, PhD2,†,
- Jorden Boone, MSc3,
- Wouter Arrazola de Oñate, MD4,5,
- Naïma Hammami, MD/MPH6,
- Christel Faes, PhD1 and
- Niel Hens, PhD1,2
- 1Interuniversity Institute for Biostatistics and statistical Bioinformatics, Data Science Institute, Hasselt University, Hasselt, Belgium
- 2Centre for Health Economics Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
- 3KPMG Advisory, Public Sector practice, Zaventem, Belgium
- 4Belgian Lung and Tuberculosis Association, Brussels, Belgium
- 5Flemish Association for Respiratory Health and Tuberculosis, Leuven, Belgium
- 6Department of Infectious Disease Prevention and Control, Agency for Care and Health, Flemish Region, Brussels, Belgium
- ↵*Corresponding author: cecile.kremer{at}uhasselt.be, +32 11 268200, Martelarenlaan 42, 3500 Hasselt, Belgium
↵† These authors contributed equally
Posted October 06, 2022.
Key performance indicators of COVID-19 contact tracing in Belgium from September 2020 to December 2021
